Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Kulp MT, Sinnott LT, Cotter SA, Borsting E, Toole AJ, Chen AM, Jenewein EC, Morrison AM, Plaumann MD, Jones-Jordan L, Mitchell GL, Tea YC, Scheiman MM; Convergence Insufficiency Treatment Trial (CITT) Investigator Group; Convergence Insufficiency Treatment Trial - Attention, Reading Trial (CITT-ART) Investigator Group. Kulp MT, et al. Among authors: plaumann md. Ophthalmic Physiol Opt. 2022 Jan;42(1):59-70. doi: 10.1111/opo.12911. Epub 2021 Nov 3. Ophthalmic Physiol Opt. 2022. PMID: 34730250 Free PMC article.
Effectiveness of vergence/accommodative therapy for accommodative dysfunction in children with convergence insufficiency.
Chen AM, Roberts TL, Cotter SA, Kulp MT, Sinnott LT, Borsting EJ, Tea YC, Jones-Jordan LA, Hertle R, Mitchell GL, Eugene Arnold L, Chase C, Scheiman MM; Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART) Investigator Group. Chen AM, et al. Ophthalmic Physiol Opt. 2021 Jan;41(1):21-32. doi: 10.1111/opo.12747. Epub 2020 Oct 29. Ophthalmic Physiol Opt. 2021. PMID: 33119180 Free PMC article. Clinical Trial.
Vergence/accommodative therapy for symptomatic convergence insufficiency in children: Time course of improvements in convergence function.
Jenewein EC, Cotter S, Roberts T, Kulp M, Mitchell GL, Jones-Jordan LA, Chen AM, Hopkins K, Huang K, Amster D, Fecho G, Tyler J, Meiyeppen S, Scheiman M; Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART) Investigator Group. Jenewein EC, et al. Ophthalmic Physiol Opt. 2023 Jan;43(1):105-115. doi: 10.1111/opo.13062. Epub 2022 Oct 22. Ophthalmic Physiol Opt. 2023. PMID: 36271753 Free PMC article.
Eight-Year Outcomes of Bilateral Lateral Rectus Recessions versus Unilateral Recession-Resection in Childhood Basic-Type Intermittent Exotropia.
Donahue SP, Chandler DL, Wu R, Marsh JD, Law C, Areaux RG Jr, Ghasia FF, Li Z, Kraker RT, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Donahue SP, et al. Ophthalmology. 2024 Jan;131(1):98-106. doi: 10.1016/j.ophtha.2023.09.004. Epub 2023 Sep 9. Ophthalmology. 2024. PMID: 37696452 Clinical Trial.
Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia.
Writing Committee for the Pediatric Eye Disease Investigator Group; Pediatric Eye Disease Investigator Group; Chen AM, Erzurum SA, Chandler DL, Hercinovic A, Wu R, Vricella M, Waters AL, Ticho BH, Erickson JW, Han S, McDowell PS, Li Z, Kraker RT, Holmes JM, Cotter SA. Writing Committee for the Pediatric Eye Disease Investigator Group, et al. JAMA Ophthalmol. 2024 May 1;142(5):417-428. doi: 10.1001/jamaophthalmol.2024.0276. JAMA Ophthalmol. 2024. PMID: 38536764 Clinical Trial.
One-year follow-up of clinical convergence measures in children enrolled in the Convergence Insufficiency Treatment Trial-Attention and Reading Trial.
Morrison AM, Kulp MT, Cotter SA, Scheiman MM, Jenewein EC, Roberts TL, Mitchell GL, Arnold LE, Retnasothi D, Bade A, Hertle R, Borsting E; Convergence Insufficiency Treatment Trial—Attention and Reading (CITT‐ART) Investigator Group. Morrison AM, et al. Ophthalmic Physiol Opt. 2024 Nov;44(7):1346-1353. doi: 10.1111/opo.13378. Epub 2024 Aug 14. Ophthalmic Physiol Opt. 2024. PMID: 39141379 Clinical Trial.